TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility GlobeNewswire November 13, 2025 MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third quarter ended September 30, […]